Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-09-12

FDA Approved: ADRENALIN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approves a supplemental labeling application for Adrenalin (epinephrine) submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADRENALIN (Epinephrine)
  • EPINEPHRINE AND ISOPROPYL ALCOHOL (EPINEPHRINE)

Snippet

SUPPL AP for ADRENALIN (EPINEPHRINE)